Navigation Links
Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease
Date:11/15/2010

SAN DIEGO, Nov. 15, 2010 /PRNewswire-- Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Orphan drug designation is awarded to drugs and biologics which are being developed for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US. This designation provides companies with financial incentives that can help support development, as well as market exclusivity if the compound is ultimately approved for sale by the FDA. As with all biopharmaceutical products, MP4CO will only receive FDA marketing approval if it is first shown to be safe and effective in human clinical trials, which have yet to be performed.

MP4CO is designed to deliver therapeutic levels of carbon monoxide (CO) to patients suffering from a sickle cell crisis. CO stabilizes hemoglobin S, an abnormal type of hemoglobin, and prevents sickling of red blood cells. The addition of MP4CO to existing treatment protocols may alleviate pain associated with a sickle cell crisis and potentially reduce the duration of a crisis. Clinically, this could mean preventing hospitalization or shorter hospital stays, reducing the need for addictive narcotic analgesics, and an improved quality of life for patients with sickle cell disease.

"This orphan drug designation is another significant milestone in the development of the MP4CO product," said Brian O'Callaghan, President and Chief Executive Officer of Sangart. "We look forward to working closely with the FDA on our clinical prog
'/>"/>

SOURCE Sangart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
2. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
7. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
8. CryoCor Receives FDA Approval for Right Atrial Flutter
9. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
10. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
11. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 /PRNewswire/ - Medicure Inc. (the "Company") ... has approved the grant of an aggregate of 236,070 ... and consultants of the Company pursuant to the Company,s ... to expire on the tenth anniversary of the date ... third anniversary of the date of grant and 50,000 ...
(Date:3/27/2015)... Texas , March 27, 2015  Victoria Vein & ... services with the Astanza Duality laser in Victoria, ... vein disease as well as advanced laser treatments for a ... entering the tattoo industry to provide more services for their ... has helped many Victoria residents get ...
(Date:3/27/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... trauma patients. Available in both small (6mm) ... External Fixation System from Zimmer is a modular system that ... The XtraFix System allows surgeons to eliminate steps, ... process, resulting in saved time, costs and overall team effort. ...
Breaking Medicine Technology:Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3
... 2012   Hospira, Inc. (NYSE: HSP ), ... today announced enrollment of the first patient in a Phase ... Phase III program, which follows a successful Phase I trial ... Hospira,s EPO and the reference product, Amgen,s Epogen ® ...
... LUTHERVILLE, Md., Jan. 9, 2012  The National ... nonprofit organization that facilitates cooperation between law ... pharmaceutical manufacturers in the prevention and investigation ... the National Precursor Log Exchange (NPLEx) in ...
Cached Medicine Technology:Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program 2Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program 3Kentucky Real-Time, Stop-Sale System Is Effective In Blocking Illegal Sales Of Pseudoephedrine 2
(Date:3/27/2015)... 2015 Ticket Down is a reputable source ... in Omaha, Nebraska on Friday, May 8th and Saturday, ... dates will be added in Omaha as Garth has done ... The Garth Brooks World Tour is continuing its run throughout ... Garth Brooks and Trisha Yearwood will bring their act to ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 On ... along with former Detroit Lions wide receiver Herman ... and educational presentation on substance abuse, treatment options ... those who attended were pastors, ministers and bishops ... and other distinguished guests. , “Our ‘Fighting Addiction ...
(Date:3/27/2015)... According to Health Day , on ... Abstinence Syndrome (NAS) are causing alarm for Florida officials. ... process for a month of their lives- and can ... vomiting. The condition is precipitated by drug use during ... (and employing medically assisted drug treatment) will also inflict ...
(Date:3/27/2015)... March 27, 2015 GrassrootsHealth, an international ... Our Children (POC) NOW! vitamin D demonstration project April ... of South Carolina (MUSC), and will soon follow with ... at no cost to a minimum of 500 pregnant ... within these two service areas. The project will include ...
(Date:3/27/2015)... Operatic contenders and their avid audience will ... The universally acclaimed baritone Sherrill Milnes will be overseeing ... at The Merion in Evanston. The event is the ... opera singers from around the country. “This is a ... young talent in the country,” said Margaret Gergen, executive ...
Breaking Medicine News(10 mins):Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Opera Idol Competition At The Merion In Evanston 2
... at the U.S. Department of Energy,s (DOE) Brookhaven National ... subtype of botulinum neurotoxin a deadly toxin produced ... is also used in cosmetic and therapeutic applications such ... detailed structure, published online December 22, 2008, by the ...
... had no clear way to predict which of their patients ... (CKD). Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and ... a simple eight-point risk factor checklist to do just that. ... 8 and 22) of the Archives of Internal Medicine ...
... say finding suggests alternate vision routes in the brain , , ... of second sight: Scientists report that a blind man in ... even though he has no conscious sensation of seeing the ... that the human brain has ways of processing vision beyond ...
... of a key protein, dramatically increasing its ability to drive ... edition of the Journal of Thrombosis and Haemostasis . ... the inherited blood disorder that causes easy or excessive bleeding ... hemophilia is caused by a lack of a protein, factor ...
... ability to shed plaques , , MONDAY, Dec. 22 (HealthDay News) ... a double hit to the brain function of Alzheimer,s disease ... myocardin -- lessen blood flow in the brain and reduce ... amyloid beta, the protein that accumulates in damaging quantities in ...
... The Male Breast Cancer Awareness Second Annual Online Holiday Auction is ... to January 8, 2009, with proceeds going to John W. Nick ... 1995. Auction items range from exotic vacation getaways and timeshares ... family, and community, and let the bidding begin! , ...
Cached Medicine News:Health News:Scientists reveal structure of new botulism nerve toxin subtype 2Health News:Scientists reveal structure of new botulism nerve toxin subtype 3Health News:Simple model predicts those at risk for chronic kidney disease 2Health News:Simple model predicts those at risk for chronic kidney disease 3Health News:'Blind' Man Navigates Obstacle Course Without Error 2Health News:Redesigned protein accelerates blood clotting 2Health News:Redesigned protein accelerates blood clotting 3Health News:Redesigned protein accelerates blood clotting 4Health News:Holiday Online Auction - Dedicated to Awareness of Male Breast Cancer - Hosted by John W. Nick Foundation, Inc. at MaleBreastCancer.org 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: